Clicky

Roche Holding AG(RHHVF) News

Date Title
Jul 29 Why value investing has worked better outside the US
Jul 29 Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report
Jul 29 EXEL Q2 Earnings Top, Sales Miss on Lower Collaboration Revenues
Jul 29 Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
Jul 29 North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers
Jul 28 EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say
Jul 28 Tweedy Browne International Value Reduces Stake in Zurich Insurance Group AG by 74.44%
Jul 28 Pre-Q2 Earnings: Is AbbVie Stock a Portfolio Must-Have?
Jul 28 Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts?
Jul 28 Sarepta Stock Rises Despite Downgrade and FDA Probe. The Crisis Explained.
Jul 28 FDA Probes Death Of 8-Year-Old Who Received Sarepta's Elevidys
Jul 28 Roche’s Alzheimer’s therapy shows continued benefit
Jul 28 Genentech and Roche Present New Insights in Alzheimer’s Disease Research Across Its Diagnostics and Pharmaceutical Portfolios at AAIC
Jul 28 Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC
Jul 25 Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS
Jul 25 Sarepta Therapeutics' Brutal Week Continues With Bad News Out Of Europe
Jul 25 RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now?
Jul 25 Sarepta Therapeutics Acknowledges CHMP Negative Opinion for ELEVIDYS in the European Union
Jul 25 Sarepta stock falls after Elevidys fails to get backing by EU regulators
Jul 25 Roche provides regulatory update on Elevidys™ gene therapy for Duchenne muscular dystrophy in the EU